Advyzon Investment Management’s Sanofi SNY Stock Holding History

Advyzon Investment Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$299K	Buy	+6,197	New	+$289K	0.03%	535

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Advyzon Investment Management's SNY Position: Q1 2026 in Review

Advyzon Investment Management opened a new position in Sanofi (SNY) in Q1 2026: 6,197 shares worth $299K. The stake represents 0.03% of the portfolio and ranks #535 among its holdings.

739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Advyzon Investment Management held 6,197 shares of Sanofi worth $299K as of Q1 2026.
Sanofi was a new Advyzon Investment Management position in Q1 2026.
Sanofi made up 0.03% of Advyzon Investment Management's portfolio in Q1 2026, its #535 holding.
739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Advyzon Investment Management's 13F filing for Q1 2026, filed 12 May 2026.